Skip to main content

Business

Zizi Elsisi, BPharm; Ana L. Hincapie, PhD; Jeff Jianfei Guo, BPharm, PhD
Utilization Challenges of Drugs for Multiple Sclerosis in a Medicaid Population
James T. Kenney, RPh, MBA
Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH
Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?
Atheer A. Kaddis, PharmD
Cori Gray, PharmD; James T. Kenney, RPh, MBA
Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods
Gary Branning, MBA
Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh
The Impact of Quality Care on a Medicaid Population with Hyperkalemia
Byron C. Scott, MD, MBA
David Campbell, PharmD, MS; Marlo Blazer, PharmD, BCOP; Lisa Bloudek, PharmD, MS; John Brokars, MS; Dinara Makenbaeva, MD, MBA
The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs
James T. Kenney, RPh, MBA
Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD
Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?
Gary M. Owens, MD
Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD
Joshua A. Roth, PhD, MHA; Theo deVos, PhD; Scott D. Ramsey, MD, PhD
Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH
Kathryn Fitch, RN, MEd; Xiaoyun Pan, MS, PhD; Jocelyn Lau, MPH; Tyler Engel, ASA, MAAA; Krithika Rajagopalan, MS, PhD
Page 3 of 16
Results 21 - 30 of 156